End-stage Kidney Disease Clinical Trials in Durham, North Carolina
2 recruitingDurham, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Duke APOL1 Research Biorepository
End-stage Kidney Disease
Duke University200 enrolled1 locationNCT04160507